Company: ImmuniWeb
Founder, CEO and Chief Architect: Dr. Ilia Kolochenko
Website: https://www.immuniweb.com
About ImmuniWeb
ImmuniWeb SA is a global cybersecurity company headquartered in Geneva, Switzerland, with regional offices in London, Dubai and Washington, DC. Founded in 2019, ImmuniWeb currently serves over 1,000 customers from more than 60 countries. ImmuniWeb is an ISO 27001 and ISO 9001 certified and CREST accredited company.
Founded by a team of cybersecurity veterans, the company has been profitable, cashflow positive and rapidly growing since its incorporation. The award-winning ImmuniWeb® AI Platform helps enterprise customers to discover, test and protect their web and mobile applications, APIs and microservices, cloud and network infrastructure, as well as to continually monitor third-party systems processing corporate data to prevent supply chain attacks.
Providing one of the most comprehensive offerings of products and services in the industry, ImmuniWeb® AI Platform offers over 25 use cases related to cybersecurity, compliance and privacy. ImmuniWeb’s proprietary AI technology is a recipient of numerous awards and industry recognition for practical usage of AI, including Gartner Cool Vendor, IDC Innovator and SC Awards Europe.
Since its incorporation, ImmuniWeb has embraced Machine Learning and AI for intelligent automation and acceleration of various cybersecurity tasks. It received its first international award (SC Awards) for the practical use of Machine Learning and AI in 2019, far before AI became mainstream after the release of ChatGPT in late 2022. From the outset, ImmuniWeb has been prudent with claims about AI’s power and limits, emphasizing that no AI can fully replace qualified human beings but can only augment them. This scientifically backed and transparent position remained unchanged with the introduction of LLMs: at ImmuniWeb, we still believe no AI can fully replace human experts. Our customers value our no-hype and no-FUD stance on AI in cybersecurity and cyber-defence.
Our Machine Learning and AI technology intelligently automates and accelerates numerous tasks and processes, offering a significant cost reduction and faster delivery of service to our customers. As a result, ImmuniWeb has been consistently delivering the best price/quality ratio to clients. To surpass the competition on the global market, we continually invest significant resources to build and fine-tune our purpose-specific AI models. These are cheaper to build, train, and operate than general-purpose LLMs, ultimately reducing costs for end customers. To prevent AI deficiencies such as hallucinations from affecting the quality of our services, all business-critical tasks are either led or verified by human experts. This enables a contractual zero false-positives SLA with a money-back guarantee for a single false positive in a report. We have operated under this SLA since 2020, and after conducting tens of thousands of tests, we have received zero complaints for a non-respect of the SLA.
Our award-winning AI technology is used across all products on the ImmuniWeb® AI Platform, including Continuous Threat Exposure Management (CTEM) and Penetration Testing as a Service (PTaaS). For CTEM, AI reliably reduces noise in Dark Web findings and improves shadow IT attribution. In PTaaS, AI enables faster and smarter detection and exploitation of web and mobile application vulnerabilities, including OWASP Top 10 for LLMs. The platform also offers 75+ DevSecOps and CI/CD integrations with leading service providers such as Microsoft, AWS, and Google.
Want to find out what TechRound can do for your business?
